Startups
Pharvaris

Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Seedtable Score

Score icon 40

Locations

Company Size

  • 11 to 50

Last Stage Round

Industry

Insights

Total Funding
$80.0M
Investors